Stevens-Johnson syndrome and toxic epidermal necrolysis: a report of six cases.

Kara A, Devrim İ, Çağlar İ, Bayram N, Kundak S, Apa H, Altan EV. Stevens-Johnson syndrome and toxic epidermal necrolysis: a report of six cases. Turk J Pediatr 2019; 61: 538-543. Stevens-Johnson syndrome and toxic epidermal necrolysis are severe cutaneous adverse reactions commonly caused by exposure to drugs and can end up with significant morbidity and mortality. We reported our experience with six patients who were diagnosed with Stevens-Johnson Syndrome or Toxic Epidermal Necrolysis with a different clinical presentation. In patients, drugs and Mycoplasma pneumoniae infection were implicated as a trigger. Intravenous Immunoglobulin treatment was given to all patients, and intensive treatment was applied for skin and mucosal lesions. The median period of stay in hospital was 13.5 days. The most common long-term complication was ocular involvement. Among six patients, corneal epithelial defects occurred in one patient. Consequently, ophthalmological evaluation should be performed both at the time of diagnosis and before hospital discharge.

[1]  Y. Canıtez,et al.  Evaluation of the patients diagnosed with Stevens Johnson syndrome and toxic epidermal necrolysis: a single center experience. , 2016, Turk pediatri arsivi.

[2]  J. Ocampo-Candiani,et al.  Actualidades en farmacodermias severas: síndrome de Stevens-Johnson (SSJ) y necrólisis epidérmica tóxica (NET) , 2015 .

[3]  N. Shear,et al.  Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: An Update , 2015, American Journal of Clinical Dermatology.

[4]  A. Mawson,et al.  Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis (SJS/TEN): Could Retinoids Play a Causative Role? , 2015, Medical science monitor : international medical journal of experimental and clinical research.

[5]  S. Aronoff,et al.  Intravenous immunoglobulin in the treatment of Stevens–Johnson syndrome and toxic epidermal necrolysis: a meta‐analysis with meta‐regression of observational studies , 2015, International journal of dermatology.

[6]  V. García-Patos,et al.  A review of causes of Stevens–Johnson syndrome and toxic epidermal necrolysis in children , 2013, Archives of Disease in Childhood.

[7]  A. Gripp,et al.  Toxic epidermal necrolysis induced by lansoprazole* , 2013, Anais brasileiros de dermatologia.

[8]  Y.-C. Huang,et al.  The efficacy of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis: a systematic review and meta‐analysis , 2012, The British journal of dermatology.

[9]  M. Mockenhaupt.  The current understanding of Stevens–Johnson syndrome and toxic epidermal necrolysis , 2011, Expert review of clinical immunology.

[10]  J. Roujeau,et al.  Systematic review of treatments for Stevens–Johnson syndrome and toxic epidermal necrolysis using the SCORTEN score as a tool for evaluating mortality , 2011, Therapeutic advances in drug safety.

[11]  Z. Ikezawa,et al.  Statistical analysis of Stevens-Johnson syndrome caused by Mycoplasma pneumonia infection in Japan. , 2011, Allergology international : official journal of the Japanese Society of Allergology.

[12]  Lucila I. Castro-Pastrana,et al.  A systematic review of treatment of drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in children. , 2011, Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharamcologie clinique.

[13]  M. Camilleri,et al.  Clinical, etiologic, and histopathologic features of Stevens-Johnson syndrome during an 8-year period at Mayo Clinic. , 2010, Mayo Clinic proceedings.

[14]  N. Koizumi,et al.  Diagnosis and treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis with ocular complications. , 2009, Ophthalmology.

[15]  S. Tseng,et al.  Erythema Multiforme, Stevens-Johnson Syndrome, and Toxic Epidermal Necrolysis: Acute Ocular Manifestations, Causes, and Management , 2007, Cornea.

[16]  Lars E French,et al.  Toxic epidermal necrolysis and Stevens Johnson syndrome: our current understanding. , 2006, Allergology international : official journal of the Japanese Society of Allergology.

[17]  C. Yeung,et al.  The timing of intravenous immunoglobulin therapy in Stevens–Johnson syndrome and toxic epidermal necrolysis , 2005, Clinical and experimental dermatology.

[18]  M. Yoshita,et al.  MRI of segmental zoster paresis , 2005, Neurology.

[19]  R. S. Padilla,et al.  Treatment of toxic epidermal necrolysis with high-dose intravenous immunoglobulins: multicenter retrospective analysis of 48 consecutive cases. , 2003, Archives of dermatology.

[20]  M. Spies,et al.  Treatment of extensive toxic epidermal necrolysis in children. , 2001, Pediatrics.

[21]  R. Stern,et al.  Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. , 1993, Archives of dermatology.

[22]  J. Roujeau,et al.  Toxic epidermal necrolysis. Clinical findings and prognosis factors in 87 patients. , 1987, Archives of dermatology.